Results 271 to 280 of about 4,823,404 (316)
Some of the next articles are maybe not open access.
Gastrointestinal cancer in Iran
Journal of Chronic Diseases, 1971Abstract Comparing the minimal incidence of gastrointestinal cancers in Southern Iran to the true incidence of same in Connecticut, it appears that all such cancers with the possible exception of those of the colon and pancreas, are more frequent in the younger population of Iran. Furthermore, upper gastrointestinal cancers seem more frequent in Iran,
P, Haghighi, K, Nasr
openaire +2 more sources
Chronotherapy for gastrointestinal cancers
Current Opinion in ONCOLOGY, 1996Chronotherapy consists in the administration of medicines according to biological rhythms. Further insight into the mechanisms of the circadian system has led to adapting the delivery of cancer chemotherapy to rhythms in drug metabolism or cell proliferation.
openaire +2 more sources
Pertuzumab in gastrointestinal cancer
Expert Opinion on Biological Therapy, 2015Human epidermal growth factor receptor 2 (HER2) and HER3 are altered in multiple tumor types, including gastrointestinal cancer. The HER2/HER3 dimer is crucial for HER2-mediated signaling in HER2-positive tumors. HER2-targeting agents, including trastuzumab, lapatinib, trastuzumab emtansine, and pertuzumab, have been approved for the treatment of HER2 ...
Do-Youn, Oh, Yung-Jue, Bang
openaire +2 more sources
Gastrointestinal peptides and cancer
Trends in Endocrinology & Metabolism, 1993The term gastrointestinal peptide is usually used to refer to a group of peptides with relatively low molecular weight (generally
M L, Silen, J D, Gardner
openaire +2 more sources
The Microbiome in Gastrointestinal Cancers
Gastroenterology Clinics of North America, 2022The human microbiome has been recognized as increasingly important to health and disease. This is especially prescient in the development of various cancers, their progression, and the microbiome's modulation of various anticancer therapeutics. Mechanisms behind these interactions have been increasingly well described through modulation of the host ...
Michael G, White, Jennifer A, Wargo
openaire +2 more sources
Salt and gastrointestinal cancer
Nutrition and Cancer, 1988This study reports on the taste for salt among patients with gastric, colon, or rectal cancers and among population controls, within the scope of an investigation on those cancers in two Belgian provinces. Among people who systematically added salt to their food, the relative risks observed were as follows: 1.78 for gastric cancer, 1.53 for colon ...
openaire +2 more sources
Nutrition and gastrointestinal cancer
Current Opinion in Clinical Nutrition and Metabolic Care, 2001The present review addresses data from randomized clinical trials on perioperative nutrition in patients with gastrointestinal cancer. It is important to appreciate that different approaches can be used with regard to timing of administration of nutritional support (preoperative versus postoperative), route of administration (parenteral versus enteral)
openaire +2 more sources
Chemoprevention of gastrointestinal cancer
Cancer and Metastasis Reviews, 1997Gastrointestinal cancer remains a significant public health threat in developed countries. Even with breath-taking gains in our understanding of the molecular underpinnings of the most common GI cancers, it is clear that the best hope in the foreseeable future lies in the chemoprevention of recurrent cancer and its associated precursors.
R G, Montoya, M J, Wargovich
openaire +2 more sources
Sarcopenia in gastrointestinal cancers
International Journal of Clinical OncologySarcopenia, characterized by loss of skeletal muscle mass and function, is a highly prevalent yet often overlooked condition in patients with gastrointestinal (GI) cancers. Emerging evidence suggests that sarcopenia is a significant predictor of poor prognosis across various stages of GI cancers.
Tomoya Emori +3 more
openaire +2 more sources
NSAIDS and gastrointestinal cancer
Prostaglandins & Other Lipid Mediators, 2015A large body of evidence from epidemiological and preclinical studies have shown that nonsteroideal anti-inflammatory drugs (NSAIDs) have a chemopreventive effect on gastrointestinal cancers and, more specifically, in colorectal cancer. This review highlights recent advances in our understanding of the role of NSAIDs in colorectal cancer prevention and
Elena, Piazuelo, Angel, Lanas
openaire +2 more sources